| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Revenue | $50.3M | +16.6% |
| Cost of Revenue | $31.2M | +19.3% |
| Gross Profit | $19.1M | +12.3% |
| R&D Expense | $4.9M | +53.0% |
| SG&A Expense | $27.8M | +23.2% |
| Operating Income | -$16.9M | -93.0% |
| Interest Expense | $3.9M | +33.4% |
| Pre-tax Income | -$13.5M | -1855.1% |
| Income Tax | -$209K |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.6M | -31.2% |
| Short-term Investments | $14K | -8.4% |
| Accounts Receivable | $6.0M | -23.7% |
| Inventory | $9.5M | +68.5% |
| Current Assets | $30.3M | -12.9% |
| Total Assets | $45.8M | -13.6% |
| Current Liabilities | $25.5M | +29.8% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.1M | -60.1% |
| Capital Expenditures | $1.8M | +72.5% |
| Investing Cash Flow | $6.6M | +686.1% |
| Financing Cash Flow | $5.0M | +13.0% |
| Free Cash Flow | -$17.9M | -61.3% |
| -155.5% |
| Net Income | -$13.0M | -66.8% |
| Long-term Debt |
| $20.6M |
| +25.5% |
| Total Liabilities | $31.1M | +5.9% |
| Stockholders' Equity | $13.9M | -38.3% |